2,3-DIHYDRO-ISOINDOLE-1-ON DERIVATIVE AS BTK KINASE SUPPRESSANT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME
The present invention relates to a compound selected from the group consisting of a compound represented by chemical formula 1, a pharmaceutically acceptable salt thereof, an ester, a prodrug, a hydrate, a solvate, and an isomer thereof, to a use of said compound for treating, relieving, or preventi...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
10.10.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a compound selected from the group consisting of a compound represented by chemical formula 1, a pharmaceutically acceptable salt thereof, an ester, a prodrug, a hydrate, a solvate, and an isomer thereof, to a use of said compound for treating, relieving, or preventing diseases related to the disorder or deregulated activity of a protein kinase, to a pharmaceutical composition comprising the compound as an active ingredient, and to a method for treatment, relief, or prevention using the compound. The compound of the present invention may be effectively used in treating, relieving, or preventing diseases related to the disorder or deregulated activity of a protein kinase.
La presente invención provee un compuesto seleccionado a partir del grupo que consiste en un compuesto de una fórmula (1) sus sales, ésteres, profármacos, hidratos, solvatos e isómeros del mismo, farmacéuticamente aceptables; un uso del compuesto para el tratamiento, alivio o prevención de enfermedades ocasionadas por actividad anómala o descontrolada de la proteínquinasa, y un uso del compuesto para la manufactura de un medicamento para el tratamiento, alivio o prevención de las enfermedades; una composición farmacéutica que comprende el compuesto como un ingrediente activo; y un método para el tratamiento, alivio o prevención de las enfermedades, utilizando el compuesto. El compuesto inventivo es útil para el tratamiento, alivio o prevención de las enfermedades ocasionadas por actividad anómala o descontrolada de la proteínquinasa. |
---|---|
Bibliography: | Application Number: MX20210011563 |